Recalls / Active ingredient / Darifenacin Hydrobromide
Darifenacin Hydrobromide
2 FDA drug recalls involving the active ingredient “Darifenacin Hydrobromide”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | Darifenacin Extended-release Tablets 15 mg 30 Tablets Rx only, Manufactured by: Torrent Pharmaceuticals, LTD | Cardinal Health Inc. |
| 2021-03-15 | Class II | Darifenacin Extended-release Tablets 7.5 mg 30 Tablets Rx only Manufactured by: Torrent Pharmaceuticals LTD. I | Cardinal Health Inc. |